Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Otitis externa: Review and clinical update.

J David Osguthorpe1, David R Nielsen

  • 1Otolaryngology and Communicative Sciences Department, Medical University of South Carolina, 135 Rutledge Avenue, Charleston, SC 29425, USA.

American Family Physician
|November 23, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tunable and Efficient CO<sub>2</sub> Delivery Supports Robust Malic Acid Production by Escherichia coli in a Hollow Fiber Membrane Bioreactor.

Biotechnology and bioengineering·2026
Same author

Engineering De Novo Monoethanolamine Production From Glucose in Escherichia coli.

Biotechnology and bioengineering·2025
Same author

Phase separation to buffer growth-mediated dilution in synthetic circuits.

Cell·2025
Same author

Tuning the Surface Properties and Biofouling Resistance of Fluorinated Siloxane Copolymers.

Langmuir : the ACS journal of surfaces and colloids·2025
Same author

Photosynthetic sorbitol production in Synechococcus sp. PCC 7002 is enhanced by addressing phosphatase promiscuity, nutrient availability and Calvin cycle bottlenecks.

Metabolic engineering·2025
Same author

Highly iterated palindrome 1 sequence improves Synechococcus sp. PCC 7002 transformation efficiencies in a homology- and methylation-dependent manner.

Biotechnology progress·2025

Otitis externa, an ear infection, affects 4 in 1,000 annually (acute) or 3-5% of the population (chronic). Treatment ranges from acidifying solutions for early stages to antibiotics for severe cases, with prevention focusing on ear canal care.

Area of Science:

  • Otolaryngology
  • Infectious Diseases
  • Dermatology

Background:

  • Otitis externa presents in acute and chronic forms, with distinct epidemiological impacts.
  • Acute otitis externa is primarily caused by bacterial or fungal overgrowth.
  • Chronic otitis externa is often linked to underlying dermatologic or allergic conditions.

Purpose of the Study:

  • To outline the epidemiology and common etiologies of otitis externa.
  • To describe the clinical presentation and progression of acute and chronic otitis externa.
  • To detail the treatment strategies and preventive measures for otitis externa.

Main Methods:

  • Literature review of otitis externa prevalence and causative agents.
  • Clinical description of disease progression and symptomology.

Related Experiment Videos

  • Summary of current therapeutic approaches and preventative recommendations.

    • Main Results:

    • Acute otitis externa affects 4/1000 persons annually; chronic affects 3-5% of the population.
    • Bacterial pathogens cause 90% of acute cases, with fungal pathogens in 10%.
    • Early symptoms include pruritus and discomfort; advanced stages involve edema, discharge, and pain.

    Conclusions:

    • Treatment varies from topical acidifying solutions for early acute cases to oral antibiotics for advanced or severe disease.
    • Antimicrobial ototopicals are preferred for later-stage acute otitis externa.
    • Prevention strategies focus on minimizing ear canal moisture, trauma, and irritant exposure.